Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, Mar... ( MONTVALE N.J. Feb. 28 /- MemoryPh...)

Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008

Date:2/28/2008

MONTVALE, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced today that it will report its fourth quarter and full year 2007 financial results on Thursday, March 6, 2008, before the U.S. financial markets open. Management will provide a Company update and discuss the financial results during a conference call on Thursday, March 6, 2008, at 9:00 a.m. EST.
Investors and other interested parties may access the call as follows:

Date: Thursday, March 6, 2008

Time: 9:00 a.m. EST

Telephone (U.S.): 800.599.9829

Telephone (international): 617.847.8703

Participant Passcode: 91069592

Webcast: http://www.memorypharma.com under the

"Investors" section

An audio replay of the conference call will be available from 11:00 a.m. EST on Thursday, March 6, 2008, until Thursday, March 13, 2008. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 63677090. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and, schizophrenia. For additional information, please visit our website at http://www.memorypha
'/>"/>

0

GOOD

Page: 1 2
Related biology technology :

1. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
2. Scientists synthesize memory in yeast cells
3. Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster
4. Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster
5. Scientists synthesize memory in yeast cells
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
8. ASU researchers improve memory devices using nanotech
9. Memory Pharmaceuticals to Announce Third Quarter Results on Thursday, November 8, 2007
10. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
11. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment

Post Your Comments:

Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, Mar...( MONTVALE N.J. Feb. 28 /- MemoryPh...)